Here is the latest shareholding Pattern of SUN PHARMA. For more details, see the SUN PHARMA financial fact sheet and SUN PHARMA share price. For a sector overview, read our pharmaceuticals sector report.
No. of Mths Qtr. Ending |
3
Jun-22 |
3
Sep-22 |
3
Dec-22 |
3
Mar-23 |
3
Jun-23 |
3
Sep-23 |
3
Dec-23 |
3
Mar-24 |
||
---|---|---|---|---|---|---|---|---|---|---|
Indian Promoters | % | 54.48 | 54.48 | 54.48 | 54.48 | 54.48 | 54.48 | 54.48 | 54.48 | |
Foreign Promoters | % | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Total Promoters | % | 54.48 | 54.48 | 54.48 | 54.48 | 54.48 | 54.48 | 54.48 | 54.48 | |
Mutual Funds | % | 11.84 | 12.22 | 12.46 | 12.91 | 13.16 | 13.07 | 12.93 | 12.21 | |
Financial institution/Banks/Insurance | % | 7.74 | 6.53 | 5.69 | 5.23 | 5.27 | 5.16 | 5.09 | 5.12 | |
Government | % | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
FII | % | 14.95 | 15.99 | 16.87 | 16.88 | 16.48 | 16.78 | 17.08 | 17.72 | |
Other | % | 0.08 | 0.89 | 0.99 | 1.10 | 1.32 | 1.43 | 1.49 | 1.49 | |
Total Institution | % | 34.61 | 35.63 | 36.01 | 36.12 | 36.23 | 36.44 | 36.59 | 36.54 | |
Bodies Corporate | % | 2.90 | 2.31 | 2.31 | 2.28 | 2.25 | 2.15 | 2.14 | 2.09 | |
Individuals | % | 6.31 | 5.91 | 5.76 | 5.70 | 5.65 | 5.55 | 5.41 | 5.44 | |
NRIs/OCBs | % | 0.31 | 0.30 | 0.28 | 0.29 | 0.27 | 0.29 | 0.29 | 0.29 | |
ADR/GDR | % | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Others | % | 1.39 | 1.36 | 1.16 | 1.14 | 1.12 | 1.08 | 1.08 | 1.15 | |
Total Non-Institution | % | 10.91 | 9.88 | 9.51 | 9.41 | 9.29 | 9.07 | 8.92 | 8.97 | |
Total Public | % | 46.00 | 46.00 | 46.00 | 46.00 | 46.00 | 46.00 | 46.00 | 46.00 | |
Grand Total | % | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | |
Pledged Promoter Holding | % | 4.04 | 2.53 | 1.92 | 1.78 | 2.29 | 2.44 | 2.44 | 2.05 | |
Subscriber Feature |
More Pharmaceuticals Company Shareholding Pattern: CIPLA ZYDUS LIFESCIENCES DIVIS LABORATORIES DR. REDDYS LAB MANKIND PHARMA
After opening the day on positive note, Indian share markets continued the momentum as the session progressed and ended on firm footing.